THE EFFECT OF VARIOUS HEPATOPROTECTORS ON PATHOLOGICAL SYNDROMES IN CHRONIC LIVER DISEASES AND DETERMINATION OF THE SPECIFIC GRAVITY OF DRUG GROUPS

Authors

  • NURBAEV FARMON ERGASHEVICH DS in Medicine, Associate Professor, Department of Folk Medicine and Professional Diseases
  • UMAROV FIRUZ KHOLMURODOVICH Assistant of the Department of Rehabilitation, Sports Medicine and Physical Culture
  • YULDASHOVA SHAKHLO TOYIROVNA Assistant of the Department of the Public Health and Healthcare Management Bukhara State Medical Institute, Bukhara, Uzbekistan

Keywords:

chronic hepatitis, cirrhosis, hepatoprotector,, cholestasis, cytolytic syndrome

Abstract

 Chronic hepatitis, cirrhosis of the liver and their consequences remain a global medical and social problem in the world. In the clinical practice of previous years, a variety of drugs were used as means of pathogenetic therapy, many of which turned out to be ineffective and went out of use. At the same time, widely known data on the ability of liver tissue to regenerate allow a rather high assessment of the prospects and potential possibilities of pathogenetic therapy of chronic hepatitis and cirrhosis using hepatoprotectors

Downloads

Published

2021-01-22

Issue

Section

Articles

How to Cite

THE EFFECT OF VARIOUS HEPATOPROTECTORS ON PATHOLOGICAL SYNDROMES IN CHRONIC LIVER DISEASES AND DETERMINATION OF THE SPECIFIC GRAVITY OF DRUG GROUPS. (2021). JournalNX - A Multidisciplinary Peer Reviewed Journal, 6(10), 232-236. https://repo.journalnx.com/index.php/nx/article/view/262